Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Scientific Reports|December 7, 2021
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcomeAtaaillah Benhaddou, Laetitia Gaston, Gaëlle Pérot, et al.
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
Nature Communications|September 12, 2024
A metabolic crosstalk between liposarcoma and muscle sustains tumor growthGabrielle Manteaux, Alix Amsel, Blanche Riquier-Morcant, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETOJean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
The Lancet. Oncology|August 10, 2024
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trialJean-Yves Blay, Quentin Devin, Florence Duffaud, et al.
Eclinicalmedicine|June 15, 2026
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in FranceJean-Yves Blay, Vincent Thevenet, Emmanuel Oger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2025
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement - OSAMA Study)Domenico Ferraioli, Fulvio Borella, Marie Meurer, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
Pageof 5